"Release of growth factors in PRP activated with thrombin."

Similar documents
THE SCIENCE OF PLATELET RICH PLASMA

Research Study. Comparison of EmCyte GS30-PurePRP II, EmCyte GS60-PurePRP II, Arteriocyte MAGELLAN, Stryker REGENKIT THT, and ECLIPSE PRP

ARTHREX ACP. Features and Benefits: Introduction

Discover TruPRP. PRP the way you want it.

Discover TruPRP. PRP the way you want it.

The Power in You. TM

SmartPReP 2: The Gold Standard

Double Syringe System Autologous Conditioned Plasma

Get the most out of Pure PRP

BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.

Research Study Comparison of. Angel Whole Blood Separation System and EmCyte PurePRP

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.

Artist Proof: Clotalyst. Autologous Serum Collection System

DRG International, Inc., USA Fax: (908)

PRP Preparation. Simplicity for Success

Home Study Program. Intraoperative use of autologous platelet-rich and platelet-poor plasma for orthopedic surgery patients T

The development of platelet concentrates has generated great expectations in bone surgery.

ALL THE ESSENTIALS OF HEALING, NATURALLY

RegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength.

Arthrex Angel TM System. Indication-specific PRP and PRF gel preparations

Human IFN-γ. Pre-Coated ELISA Kit

Instructions for use. Serotonin ELISA IB89546

VIII. Validation Evaluation Comparative Chart Application Fields of PRP Advantages of MiroPRP for skin treatments MicroPRP and Mico-Mesotherapy

Chondrocyte Response To Prp Is Concentration-Dependent

All THE E SSEn TIAl S OF H EAl I ng, natu RAlly. P RIvATE PRACTICE

TROPOCELLS TM PLUS. PRP Preparation Simplicity for Success

Human IFN-α (Interferon-Alpha) Pre-Coated ELISA Kit

Human TIMP-2. Pre-Coated ELISA Kit

Median Sternotomy Closure Utilizing Platelet Concentrate BIOLOGICS

RegenKit THT. Autologous Platelet Rich Plasma (A-PRP) Reference Guide. Biologics. Concentrated on Healing

Clotalyst. Autologous Activation Solution. Surgical Technique

COMBINE FGF23 and R01 Kit. Procedure Manual (Draft)

Bone Marrow Concentration. For customized cellular concentrations of platelet-rich plasma from bone marrow aspirate

MAXIMAL PRP BANK. Utility Model Patent Registered Apply for PCT.

A.P.A.G. Activated Plasma Albumin Gel

Description. Used materials. Warnings and precautions

COLORIMETRIC SANDWICH ELISA KIT INSTRUCTION MANUAL

The Characterization and Quantification of Bioactive Components in Human Blood Clots for Tissue Healing and Engineering

Chitosan-platelet-rich plasma implants actions in vitro and in vivo

What is the future of ACL reconstruction?

Sheep IgG ELISA Kit. Innovative Research, Inc. Catalog No: ISHIGGKT. Lot No: SAMPLE

Mouse OVA IgG1 ELISA. Catalog Number M046072

HUMAN IgG. Immunoperoxidase Assay for Determination of IgG in Human Samples

SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric*

Porcine CRP ELISA Kit

HUMAN TRANSFORMING GROWTH FACTOR BETA 1 (TGF- 2) ELISA KIT

Instructions for use. Fast Track. Serotonin RIA BA R-8900

Mouse anti-tnf-alpha autoantibody ELISA Kit. (TNFa-Ab) ELISA kit. 96 Tests. Catalog Number: MBS Store all reagents at 2-8 C

Mouse Collagen Type III ELISA

Store samples to be assayed within 24 hours at 2-8 C. For long-term storage, aliquot and freeze samples at -20 C. Avoid repeated freeze-thaw cycles.

GSI Rabbit TGFβ1 ELISA Kit- 2 plates DataSheet

Sheep oxytocin (OT) ELISA Kit

Coagulation Cascade. TF-VIIa. Tissue Factor + VII. XIIa. Prothrombin. XIa. IXa. VIIIa. Thrombin. XL- Fibrin. XIII Monomer. Fibrinogen.

Human BDNF ELISA. For the precise measurement of BDNF in human serum, plasma, body fluids, tissue homogenate or cell culture supernates.

Human Connective Tissue Growth Factor (CTGF) Elisa Kit

Note: The taller 100 x 13 mm tube is not designed to run on the ACL TOP. Plasma after centrifugation of these tubes must be placed in sample cups.

TECHNICAL REPORT. Experimental Campaign on the in-vitro platelet-endothelial cells interactions

VWF (Human) ELISA Kit

Human CXCL4/PF4 PicoKine ELISA Kit

Bovine IgG-Ab ELISA Kit

Your Analyte ELISA Kit Instruction

Comparison of Methods for Point of Care Preparation of Autologous Platelet Gel

Porcine Interleukin 1 Beta(IL-1β) ELISA Kit

Human Calcitonin ELISA Kit

Section 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)

Hamster follicle stimulating hormone (FSH) ELISA Kit

Rat follicle-stimulating hormone (FSH) ELISA Kit

TF (Bovine) ELISA Kit

Validation of commercial ELISAs for quantifying anabolic growth factors and cytokines in canine ACD-A anticoagulated plasma

Canine Transferrin ELISA KIT

Rat Testosterone (T) ELISA Kit (OKCA00179)

Chicken Calprotectin ELISA Kit. User Manual

Human ferritin(fe) ELISA Kit

Rabbit C-reactive protein(crp) ELISA Kit

Human Anti-platelet antibody ELISA kit

Sheep Follicle Stimulating Hormone (FSH)ELISA kit

Human Alpha-2-Macroglobulin ELISA

Human Collagen Type III Alpha 1 ELISA kit

Bovine Haptoglobin ELISA

Rabbit immunoglobulin M(IgM) ELISA Kit

Human Gla-Osteocalcin High Sensitive EIA Kit

Comparison of different methods of centrifugation for preparation of platelet- rich plasma (PRP)

Rat Hemoglobin ELISA

Human Cardiac Troponin T (ctnt) ELISA

Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated Groups

To enable the learner to develop an understanding of the various stages of Intraoperative Cell Salvage (ICS)

ACP Tendo Growth factor depot

Mouse Gonadotropin Releasing Hormone (GnRH) ELISA

Mouse TNF alpha ELISA Kit

FIVEphoton Biochemicals

Guide to preparation of liquid biopsies for nucleic acid extraction

Translating Basic Science Research in the Clinical Practice of Trauma

Rat Cardiac Troponin T (ctnt) ELISA

FIVEphoton Biochemicals

Transferrin ELISA. For the quantitative determination of transferrin in human biological samples

IV3-105E. High Sensitivity CRP (hscrp) ELISA Kit. Definitions LOT REF. English. For in-vitro diagnostic use only IVD. Instructions for use

Rat α-melanocyte stimulating hormone (α-msh) ELISA Kit

Rat Cardiac Troponin I (ctni) ELISA

Anti- Tissue Transglutaminase TTG IgG ELISA Kit

Rat TAR DNA Binding Protein 43 (TDP-43) ELISA

Transcription:

"Release of growth factors in PRP activated with thrombin." Carrasco, Joaquin phd Dp. Surgery Universitat de València. Presenter Bonete, Daniel MD Hospital La Fe de València Gomar, Francisco MD Hospital Clinico Universitario Valencia Dp. Surgery Universitat de València AAOS Annual Meeting San Diego Ca. 2011

Conflict of Interest Statement The authors have nothing to disclose AAOS Annual Meeting San Diego Ca. 2011

Background Developed in the early 1990 s Platelet Gel is an autologous source of concentrated multiple growth factors.

Background The platelet alpha granules contain more than 30 bioactive proteins.. The more growth factors released into the wound, the more stem cells are stimulated to produce new host tissue.

Background Thus, one can easily see that PRP probably permits the body to heal faster and more efficiently. But, currently the clinical benefit remains questionable, because the activation of platelets is affected by many factors: the type of anticoagulant used, centrifugation speed and duration as well The amount of growth factors released

Objective The purpose of our study was to evaluate the release of growth factors, the quantification and its correlation with the number of platelets after the activation with thrombin and calcium in order to use it in our experimental works about consolidation of cortical bone fractures.

Platelets Baseline Platelet Count: We extracted from sheep peripheral blood (anticoagulant ACD-A Citra Braintree Ma).

Platelets Platelet count in PRP Peripheral blood, were centrifugated: A 500 g B 600 g for 10 min... C 750 g The platelet level is newly centrifugated at 1900 g for 8 min Activated with 1000 units of thrombin (Sigma) and 10% CaCl 2 per ml.

Growth Factors Growth Factors Determination We have determined PDGF TGF β1 by ELISA technique (R & D system)

Growth Factors Level of Growth Factors in PRP Clot is formed less than 5 minutes, Aliquots were taken off the gel on the 10 ', 60' and 180 and centrifugated at 1500 g for 5 min. and frozen at - 70º C. The TGFb1 samples required activation with 1 N HCl acid medium and incubation for 24 hours at 2-8ºC. 11

Growth Factors Basal levels of PDGF and TGFb1 Peripheral blood was collected on ice, with EDTA 1. Centrifuged at 1000 g for 30 min. 2. second centrifugation at 10000 g for 10 min at 2-8º C

Statistical Analysis At least 5 determinations were done for each value Values as means ± std with variability coefficient Analysis of variance (ANOVA). Pearson correlation with significance Student s T test. Correlation studies were considered to be statistically significant at P< 0.05 and P<0.01 13

Platelets Basal level platelets in peripheral blood Table I. Average value of the number of platelets in peripheral blood Platelets/ml Samples of blood N=5 mean 428750 std 41719,3 v.c. 0,0947 15

Platelets Table II. Average value of the number of platelets determinated in PRP by one centrifugation. Platelets/ml Centrifugated 10 min A. 500 g B. 600 g C. 750 g mean 123000 81000 36500 std 12727.9 2828.42 4949.74 v.c. 0.1034 0.0349 0,135 Note, drag effect, a second centrifugation was then necessary

Platelets Table III. value of the number of platelets determinated in PRP by a 2nd centrifugation 1900 g. Platelets/ml A. 500 g B.600 g C.750 g Mean 167,5 10 6 149,5 10 6 142 10 6 std 30,410 6 24,710 6 19,7910 6 v. c. 0,181 0,165 0,139 We significantly improve the concentration of platelets. The best method is 1st 500 g followed by 2nd of 1900 g

Material Growth y Factors Método 2,5 2,0 Calibration PDGF y=0.0011x-0.0182 Abs450-570 nm 1,5 1,0 0,5 r=0.999 The PDGF linear regression fits 0.999 0,0-0,5 0 500 1000 1500 2000 2500 pgr/ml PDGF pgr/ml PDGFvs Abs 450-570 nm linear egression

Material Growth y Factors Método calibration TGFb1 1,6 1,4 1,2 y=0.0007x-0.0563 r=0.9929 Abs450-570nm 1,0 0,8 0,6 0,4 The TGF b1 linear regression fits 0.9929 0,2 0,0 0 500 1000 1500 2000 2500 pgr/ml PDGFvs Abs 450-570 nm pgr/ml TGF b1 linear egression

Material Growth y Factors Método Table IV Basal level of growth factors in Peripheral blood mean std v. c. PDGF pgr/ml TGF β1 pgr/ml 281.31 12.79 0.045 785.48 96.94 0.123

Growth Factors kinetic of PDGF release % released 100 90 80 70 In 10 min, there is 93.88 % of PDGF released. 60 50 10 min 60 min 180 min Time after activation of platelets % released PDGF 21

Growth Factors kinetic of TGF b1 release 120 % released TGF b1 100 80 60 40 In 10 min, there is only 65 % of TGF b1released. 20 0 10 min 60 min 180 min time after platelet activation % released TGF b1 22

Growth Factors TABLE V PDGF Released A.500 g mean std v.c.. pgr/ml released % 10 min 505.0 27.0 0.0549 256.0 93.88 60 min 518.4 27.0 0.053 96.37 180 min 537.9 4.3 0.008 1.9 times 100.0 B.600 g 10 min 470.7 2.01 0.0042 189.39 100.0 60 min 454.06 19.7 0.043 96.46 180 min 427.82 21.69 0.0506 1.5 times 91.02 C.750 g 10 min 449.77 30.5 0.0678 209.58 91.62 60 min 489.88 22.7 0.0463 99.79 180 min 490.89 11.09 0.0226 1.7 times 100.0

Growth Factors TABLE VI TGF β1 Released A.500 g mean std v.c. Pgr/ml Released % 10 min 4697 900 0.19 6365 65.69 60 min 4944 49 0.009 8 times 69.14 180 min 7150 762 0.100 100.0 B.600 g 10 min 3724 200.0 0.053 3754 82.04 60 min 3935 65.5 0.016 4.7 times 86.69 180 min 4539 150 0.033 100.0 C.750 g 10 min 4324 198.0 0.045 3886 92.57 60 min 4772 250.0 0.052 4.9 times 102.1 180 min 4671 368 0.078 100.0

Growth Factors TABLA VII Pearson Correlation X(platelets) Y1(PDGF) Y2(TGFb1) Rx,y1 Rx,y2 Ry1,y2 Pearson coeficient 0.9244 0.933 0.9605 Significance T student test P<0.05 0.26 0.2535 0.1959 It is (+) correlation between platelets and growth factors even between the growth factors themselves. Significance T student test P<0.01 *0.33 *0.3145 *0.2431 Linear regression R 2 =0.855 R 2 =0.847

Discussion There is a wide variability of methods of preparation as well as different conditions of use of PRP. Are all PRP equal? 27

Discussion The method of concentration with a single centrifugation is not so, because you lose a lot of washed platelets by the cell stage both red and white. In the literature we can see therefore many authors that centrifuge a second time, to concentrate much more platelets. 28

Discussion It is asumed that the calcium participates in the activation of platelets but really calcium estimulates degranulation... Thrombin generated irreversible platelet degranulation with the loss of integrity of platelets and subsequent release of growth factors... 29

Discussion The lack of consensus on the composition and production of plasma concentrates makes it impossible to establish a standard that includes all the research. It s not known how many factors are being used 30

Discussion In our group research, a study in rabbits, by cortical defect of the tibia and fibula, the use of PRP activated only with calcium does not alter the repair and healing processes.

Discussion Thus, we studied three different speeds in response to the literature. So in our three methods used, the highest concentration of platelets were obtained by two centrifugations. 32

Discussion. We have studied the release of PDGF and TGF b1 in time. After activation with calcium and thrombin, PDGF was released practically in 10, meanwhile the release of TGF β1 was slower and sustained over time. 33

This method for obtaining concentrated platelets really becomes PRF (Plasma rich in factors). These results are consistent with those reported in the literature but these results allows us to standardize our method of work 34

Conclusion There is a direct relationship between the activated platelets and the release of growth factors. The more platelets concentrated the more growth factors are released in the first minutes.

Conclusion The kinetics are different according to each growth factor probably due to their different function in the process of healing...we are ready to use the factors in a known concentration in our trials.

Thank you for your attention